Allegra, S.; Abbadessa, G.; Chiara, F.; Di Grazia, D.; Mirabella, C.; Caudana, M.; Zanatta, M.; Bertello, J.; Voi, V.; De Francia, S.
Role of OCT1 and MAP3K5 Genetic Polymorphisms in Hydroxyurea Pharmacokinetics. Life 2025, 15, 1284.
https://doi.org/10.3390/life15081284
AMA Style
Allegra S, Abbadessa G, Chiara F, Di Grazia D, Mirabella C, Caudana M, Zanatta M, Bertello J, Voi V, De Francia S.
Role of OCT1 and MAP3K5 Genetic Polymorphisms in Hydroxyurea Pharmacokinetics. Life. 2025; 15(8):1284.
https://doi.org/10.3390/life15081284
Chicago/Turabian Style
Allegra, Sarah, Giuliana Abbadessa, Francesco Chiara, Daniela Di Grazia, Cristina Mirabella, Maura Caudana, Marina Zanatta, Jenni Bertello, Vincenzo Voi, and Silvia De Francia.
2025. "Role of OCT1 and MAP3K5 Genetic Polymorphisms in Hydroxyurea Pharmacokinetics" Life 15, no. 8: 1284.
https://doi.org/10.3390/life15081284
APA Style
Allegra, S., Abbadessa, G., Chiara, F., Di Grazia, D., Mirabella, C., Caudana, M., Zanatta, M., Bertello, J., Voi, V., & De Francia, S.
(2025). Role of OCT1 and MAP3K5 Genetic Polymorphisms in Hydroxyurea Pharmacokinetics. Life, 15(8), 1284.
https://doi.org/10.3390/life15081284
